Helicobacter pylori
_Helicobacter pylori_ is a gram-negative, flagellated, helical bacterium that infects the stomach and is the leading cause of gastritis, peptic ulcers, and potentially stomach cancer, often presenting without symptoms but occasionally causing indigestion and upper abdominal pain. It was identified as the cause of gastric ulcers in 1983 by Drs. Barry Marshall and Robin Warren.
Health Outcomes
- Accurate Enumeration of Viable Probiotic Bacteria
- Altered Antibiotic Susceptibility
- Altered Pathogenic Bacterial Biomolecules
- Antimicrobial Food Preservation
- Carbohydrate Binding Activity
- Disrupted Bacterial Cell Membranes
- Disrupted Microbial Cell Membrane Integrity
- Enhanced Antibacterial Effect
- Enhanced Bacterial Growth
- Enhanced Gastric Mucosal Defense
- Enhanced Gastric Viability
- Enhanced Pathogen Protection
- Improved Acid Stress Resistance
- Improved Antagonistic Activity Against Undesirable Microorganisms
- Improved Antibacterial Activity
- Improved Antibiotic Resistance Outcomes
- Improved Bacterial Survival Rate
- Improved Cure Rate
- Improved Functional Dyspepsia Symptoms
- Improved Gastric Acid Regulation
- Improved Gastric Mucosal Protection
- Improved Gastric Survival
- Improved Gastrointestinal Infection Outcomes
- Improved Gut Protection
- Improved H Pylori Eradication Rates
- Improved Microbial Safety
- Improved Mucosal Visibility
- Improved Quorum Sensing Signaling
- Improved Self-reported Halitosis Score
- Increased Acetic Acid Production
- Increased Acid Resistance
- Increased Antagonistic Activity Against Undesirable Microorganisms
- Increased Antibacterial Activity
- Increased Antibacterial Activity Against Pathogens
- Increased Bacterial Survival
- Increased Colonization by Administered Strain
- Increased Gastric Acid Production
- Increased Gastric Cancer Risk
- Increased Gastric Epithelial Stem/Progenitor Cell Proliferation
- Increased Gastric Survival Rate
- Increased H. pylori Eradication Rate
- Increased IgA-Inducing Activity
- Increased Resistance to Gastric Juices
- Increased Serum Gastrin Levels
- Increased Serum Gastrin-17 Level
- Increased Serum Pepsinogen Activity
- Increased Total Bacterial Load
- Increased Viable Bacteria Count
- Inhibited Pathogenic Microbes
- Inhibition of Harmful Bacterial Growth
- Maintained Antibiotic Susceptibility
- Potentially Effective Antibacterial Proteins
- Reduced Adhesion of Foodborne Pathogens
- Reduced Bacterial Colonization
- Reduced Bacterial Culturability
- Reduced Bacterial Load
- Reduced Cancer Incidence
- Reduced Duodenal pH
- Reduced Enteropathogen Activity
- Reduced Epigastric Pain
- Reduced Esophageal Cancer Risk
- Reduced Esophageal Eosinophil Count
- Reduced Expression of Cag Pathogenicity Island Genes in H. pylori
- Reduced Ferritin Level
- Reduced Gastric Cancer Pathogen Effectiveness
- Reduced Gastric Cell Death
- Reduced Gastric Epithelial Proliferation Signaling
- Reduced Gastric Injury
- Reduced Gastric Mucosal Histiocyte Numbers
- Reduced Gastric Mucosal Inflammation
- Reduced Gastric Mucosal Injury
- Reduced Gastritis Symptoms
- Reduced Gastrointestinal Cancer Risk
- Reduced Gastrointestinal Infections
- Reduced Gut Damage
- Reduced Harmful Bacteria Species
- Reduced Harmful Microorganisms
- Reduced Helicobacter pylori-Related Gastritis
- Reduced IL-8 Production in Gastric Epithelial Cells
- Reduced Incidence of Gastritis
- Reduced Infection Recurrence
- Reduced Infectious Complication
- Reduced Inflammation in Gastric Cells
- Reduced Intestinal Pathogen Bacterial Count
- Reduced Intracellular pH of Pathogenic Bacteria
- Reduced Intragastric Bacterial Load
- Reduced Microbial Growth
- Reduced Multiple Sclerosis Risk
- Reduced Pathogen Colonization
- Reduced Pathogen Infection
- Reduced Pathogen Viability
- Reduced Pathogenic Bacteria Adhesion
- Reduced Pathogenic Bacteria Levels
- Reduced Pathogenic Bacteria Load
- Reduced Pathogenic Bacterial Abundance
- Reduced Pathogenic Bacterial Activity
- Reduced Pathogenic Bacterial Populations
- Reduced Pathogenic Contamination
- Reduced Pathogenic Load
- Reduced Pathogenic Microorganisms in the Intestine
- Reduced Pepsinogen Production
- Reduced Potential Pathogenic Bacteria
- Reduced Prevalence of Gastric Symptoms
- Reduced Risk of Colorectal Cancer
- Reduced Tongue Coating Score
- Reduced Treatment Failure
- Reduced Ulcer Symptoms
- Reduced Virulence of Pathogens
- Reduced Virulence-Associated Activity
- Strain Authentication and Identification
- Suppressed Pathogenic Growth
- Synergistic Antibiotic Effect